A detailed history of State Street Corp transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, State Street Corp holds 641,195 shares of BMEA stock, worth $2.58 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
641,195
Previous 675,737 5.11%
Holding current value
$2.58 Million
Previous $3.04 Million 113.03%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$4.23 - $10.1 $146,112 - $348,874
-34,542 Reduced 5.11%
641,195 $6.48 Million
Q2 2024

Aug 14, 2024

SELL
$4.14 - $15.3 $15.8 Million - $58.3 Million
-3,809,878 Reduced 84.94%
675,737 $3.04 Million
Q1 2024

May 15, 2024

BUY
$13.92 - $19.5 $43.6 Million - $61.1 Million
3,134,667 Added 232.03%
4,485,615 $67.1 Million
Q4 2023

Feb 14, 2024

SELL
$8.37 - $19.8 $7.93 Million - $18.8 Million
-947,718 Reduced 41.23%
1,350,948 $19.6 Million
Q3 2023

Nov 14, 2023

BUY
$13.44 - $23.02 $9.82 Million - $16.8 Million
730,716 Added 46.6%
2,298,666 $31.6 Million
Q2 2023

Aug 14, 2023

BUY
$21.66 - $41.8 $32.7 Million - $63.2 Million
1,511,635 Added 2684.25%
1,567,950 $34.4 Million
Q1 2023

May 15, 2023

BUY
$6.8 - $32.35 $31,280 - $148,810
4,600 Added 8.89%
56,315 $1.75 Million
Q4 2022

Feb 14, 2023

BUY
$6.3 - $11.6 $105,210 - $193,720
16,700 Added 47.69%
51,715 $435,000
Q3 2022

Nov 15, 2022

BUY
$9.51 - $13.61 $66,570 - $95,270
7,000 Added 24.99%
35,015 $342,000
Q2 2022

Aug 15, 2022

SELL
$3.0 - $12.03 $708,888 - $2.84 Million
-236,296 Reduced 89.4%
28,015 $336,000
Q1 2022

May 16, 2022

BUY
$4.39 - $9.03 $249,360 - $512,922
56,802 Added 27.37%
264,311 $1.18 Million
Q4 2021

Feb 14, 2022

BUY
$7.22 - $12.72 $600,198 - $1.06 Million
83,130 Added 66.84%
207,509 $1.55 Million
Q3 2021

Nov 15, 2021

BUY
$10.0 - $15.99 $269,990 - $431,714
26,999 Added 27.73%
124,379 $1.49 Million
Q2 2021

Aug 16, 2021

BUY
$13.65 - $20.93 $1.33 Million - $2.04 Million
97,380 New
97,380 $1.52 Million

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $118M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.